These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38468209)

  • 1. Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registry.
    Palmér S; Blomqvist C; Holmqvist M; Lindman H; Lambe M; Ahlgren J
    BMC Cancer; 2024 Mar; 24(1):329. PubMed ID: 38468209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 years.
    Wadsten C; Heyman H; Holmqvist M; Ahlgren J; Lambe M; Sund M; Wärnberg F
    Acta Oncol; 2016 Nov; 55(11):1338-1343. PubMed ID: 27548561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study.
    Cronin-Fenton DP; Kjærsgaard A; Ahern TP; Mele M; Ewertz M; Hamilton-Dutoit S; Christiansen PM; Ejlertsen B; Sørensen HT; Lash TL; Silliman RA
    Acta Oncol; 2017 Sep; 56(9):1155-1160. PubMed ID: 28585885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
    Robertson C; Arcot Ragupathy SK; Boachie C; Dixon JM; Fraser C; Hernández R; Heys S; Jack W; Kerr GR; Lawrence G; MacLennan G; Maxwell A; McGregor J; Mowatt G; Pinder S; Ternent L; Thomas RE; Vale L; Wilson R; Zhu S; Gilbert FJ
    Health Technol Assess; 2011 Sep; 15(34):v-vi, 1-322. PubMed ID: 21951942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer.
    Osterman E; Hammarström K; Imam I; Osterlund E; Sjöblom T; Glimelius B
    Acta Oncol; 2021 Jul; 60(7):842-849. PubMed ID: 33689551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary treatment for operable primary breast cancer.
    Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark.
    Cronin-Fenton D; Kjærsgaard A; Nørgaard M; Amelio J; Liede A; Hernandez RK; Sørensen HT
    Breast Cancer Res Treat; 2018 Jan; 167(2):517-528. PubMed ID: 28948396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of case-finding algorithms for recurrence of breast cancer using routinely collected administrative data.
    Xu Y; Kong S; Cheung WY; Bouchard-Fortier A; Dort JC; Quan H; Buie EM; McKinnon G; Quan ML
    BMC Cancer; 2019 Mar; 19(1):210. PubMed ID: 30849954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of data quality in the Swedish National Register for Breast Cancer.
    Löfgren L; Eloranta S; Krawiec K; Asterkvist A; Lönnqvist C; Sandelin K;
    BMC Public Health; 2019 May; 19(1):495. PubMed ID: 31046737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.
    Dinnes J; Ferrante di Ruffano L; Takwoingi Y; Cheung ST; Nathan P; Matin RN; Chuchu N; Chan SA; Durack A; Bayliss SE; Gulati A; Patel L; Davenport C; Godfrey K; Subesinghe M; Traill Z; Deeks JJ; Williams HC;
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012806. PubMed ID: 31260100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis - results from a registry-based study from Germany.
    Holleczek B; Stegmaier C; Radosa JC; Solomayer EF; Brenner H
    BMC Cancer; 2019 May; 19(1):520. PubMed ID: 31146706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of cancer registry data for measuring the quality of breast cancer care.
    Malin JL; Kahn KL; Adams J; Kwan L; Laouri M; Ganz PA
    J Natl Cancer Inst; 2002 Jun; 94(11):835-44. PubMed ID: 12048271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring cancer register data to find risk factors for recurrence of breast cancer--application of Canonical Correlation Analysis.
    Razavi AR; Gill H; Stål O; Sundquist M; Thorstenson S; Ahlfeldt H; Shahsavar N;
    BMC Med Inform Decis Mak; 2005 Aug; 5():29. PubMed ID: 16111503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes.
    Adra J; Lundstedt D; Killander F; Holmberg E; Haghanegi M; Kjellén E; Karlsson P; Alkner S
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):285-295. PubMed ID: 31212042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population.
    Osterman E; Glimelius B
    Dis Colon Rectum; 2018 Sep; 61(9):1016-1025. PubMed ID: 30086050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data.
    Kroenke CH; Chubak J; Johnson L; Castillo A; Weltzien E; Caan BJ
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26582243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns and predictors of first and subsequent recurrence in women with early breast cancer.
    Geurts YM; Witteveen A; Bretveld R; Poortmans PM; Sonke GS; Strobbe LJA; Siesling S
    Breast Cancer Res Treat; 2017 Oct; 165(3):709-720. PubMed ID: 28677011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark.
    Collin LJ; Cronin-Fenton DP; Ahern TP; Christiansen PM; Damkier P; Ejlertsen B; Hamilton-Dutoit S; Kjærsgaard A; Silliman RA; Sørensen HT; Lash TL
    BMJ Open; 2018 Aug; 8(7):e021805. PubMed ID: 30068618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark.
    Jensen AR; Overgaard J; Storm HH
    Eur J Cancer Prev; 2002 Aug; 11(4):359-64. PubMed ID: 12195162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.